In particular, the PERK-eIF2α pathway is activated in Aβ-treated human cholinergic neuroblastoma cells, and PERK knockdown protects these cells against the pro-apoptotic effects of Aβ [73]. Here, EIF2AK3 is linked to neuroblastoma.